serpin family E member 1
Senast uppdaterad 27 May 2021
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Den SERPINE1 gene provides instructions for making a protein called plasminogen activator inhibitor 1 (PAI-1). PAI-1 is involved in normal blood clotting (hemostasis). After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss.
Videoval för GenesVideobibliotek
Normal function
Den SERPINE1 gene provides instructions for making a protein called plasminogen activator inhibitor 1 (PAI-1). PAI-1 is involved in normal blood clotting (hemostasis). After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss.
The PAI-1 protein blocks (inhibits) the action of other proteins called plasminogen activators. These proteins, including urokinase plasminogen activator (u-PA) and tissue type plasminogen activator (t-PA), convert an inactive enzyme called plasminogen to its active form, plasmin. Plasmin is involved in fibrinolysis, which is the process of dissolving blood clots. By inhibiting the conversion of plasminogen to plasmin, and thereby preventing fibrinolysis, the PAI-1 protein helps ensure that clots are only dissolved when they are no longer needed to stop bleeding.
In addition to its role in hemostasis, PAI-1 is also thought to be involved in cell movement (migration) and the breakdown and replacement (remodeling) of body tissues.
Conditions referring to this gene or chromosome
Other names
endothelial plasminogen activator inhibitor
PAI
PAI-1
PAI1
PLANH1
plasminogen activator inhibitor 1 precursor
serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
serpin E1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
Related patient information and medicines

Patient information leaflet
Kan jag ta Fenofibrat och Gabapentin tillsammans?
There are no known significant interactions between fenofibrate and gabapentin. These two medicines work in different ways and are processed by different organs in the body. Why this happens Fenofibrate is primarily broken down by the liver and affects blood fats (lipids). Gabapentin is not metabolised by the liver; it is filtered out of the body.

Patient information leaflet
Retinoblastom
Most commonly, it affects children aged under 2, including newborn babies. It is a tumour of the nerve layer of the retina, which is the light-sensitive membrane at the back of the eye. The tumour grows from t... Siblings of an affected child in a family in which no other family members have had the disease have only a small risk of disease. See.

Patient information leaflet
Alkoholbrukssyndrom
Many people drink alcohol. For some, alcohol is something that they enjoy in moderation. Wha... Alcohol use disorder means drinking alcohol in a way that causes harm. If you or a family member has alcohol use disorder then treatment and support can be provided to help you eller your family member reduce eller stop drinking alcohol. Alcohol use disorder.

Patient information leaflet
Ångest hos barn
Parents and carers can get help and advice about children's mental health from Young Minds' free parent helpline on 0808 802 5544, from Monday to Friday, 9.30 am to 4 pm. Tre... Some treatments are offered by local child mental health services and some might be offered by support organisations such as Barnado's or MIND (a mental health charity)..

Patient information leaflet
Marfans syndrom
Marfans syndrom (named after Dr Antoine Marfan, the French doctor who first described it in 1896) is a genetic disorder which people are born with and which lasts lifelong. Marfan syndrome can affect different people in different ways. Some people have mild symptoms; other people have more severe symptoms. You may have a history of Marfan syndrome.

Patient information leaflet
Alzheimers sjukdom
Alzheimer's disease is a cause of dementia. There is no cure and it can cause a great deal of distress for those affected and their families. However, early diagnosis is important because there is a great deal of support as well as medication that can help. What is Alzheimer's disease. Alzheimer's disease is the most common cause of dementia..
Vidare läsning och referenser
- serpin family E member 1; MedlinePlus, National Library of Medicine.
- Asselbergs FW, Pattin K, Snieder H, Hillege HL, van Gilst WH, Moore JH. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1. Semin Thromb Hemost. 2008 Sep;34(6):562-8. doi: 10.1055/s-0028-1103367. Epub 2008 Nov 28.
- Fay WP, Parker AC, Condrey LR, Shapiro AD. Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood. 1997 Jul 1;90(1):204-8.
- Flevaris P, Vaughan D. The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis. Semin Thromb Hemost. 2017 Mar;43(2):169-177. doi: 10.1055/s-0036-1586228. Epub 2016 Aug 24.
- Heiman M, Gupta S, Lewandowska M, Shapiro AD. Complete Plasminogen Activator Inhibitor 1 Deficiency. 2017 Aug 3 [updated 2023 Feb 23]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK447152/
- Mehta R, Shapiro AD. Plasminogen activator inhibitor type 1 deficiency. Haemophilia. 2008 Nov;14(6):1255-60. doi: 10.1111/j.1365-2516.2008.01834.x.
- Yasar Yildiz S, Kuru P, Toksoy Oner E, Agirbasli M. Functional stability of plasminogen activator inhibitor-1. ScientificWorldJournal. 2014;2014:858293. doi: 10.1155/2014/858293. Epub 2014 Oct 15.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
27 May 2021 | Senaste versionen
1 Oct 2017 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

